SCHEMBL7192597

SCHEMBL7192597

CCCOc1c(C(C)(C)CC)cc(C(C)(C)CC)c(OC(=O)C(C)(C)C)c1/C=C/C(=O)c1ccc(OC(=O)C(C)(C)C)cc1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.46
CYP1A1 P04798 2/20 0.43
CYP1B1 Q16678 2/20 0.43
DPP4 P27487 3/20 0.41
ELANE P08246 6/20 0.40
MAOB P27338 1/20 0.38
PRTN3 P24158 1/20 0.38
PTPN1 P18031 3/20 0.38
RARG P13631 1/20 0.37
RXRA P19793 1/20 0.37
PPARG P37231 1/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7192600 1.00 ABCG2 (0.46) ABCG2CYP1A1CYP1B1DPP4ELANE
SCHEMBL9276096 0.97 ABCG2 (0.43) ABCG2CYP1A1CYP1B1DPP4ELANE
SCHEMBL9276091 0.97 ABCG2 (0.43) ABCG2CYP1A1CYP1B1DPP4ELANE
SCHEMBL7804855 0.92 ABCG2 (0.47) ABCG2CYP1A1CYP1B1DPP4ELANE
SCHEMBL7184517 0.92 MAOB (0.44) ABCG2CYP1A1CYP1B1DPP4ELANE
SCHEMBL7184524 0.92 MAOB (0.44) ABCG2CYP1A1CYP1B1DPP4ELANE
SCHEMBL7804856 0.92 ABCG2 (0.47) ABCG2CYP1A1CYP1B1DPP4ELANE
SCHEMBL9277969 0.89 MAOB (0.42) ABCG2CYP1A1CYP1B1DPP4ELANE
SCHEMBL9277965 0.89 MAOB (0.42) ABCG2CYP1A1CYP1B1DPP4ELANE
SCHEMBL7187829 0.89 PTPN1 (0.43) ABCG2DPP4ELANEMAOBPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed